SANOFI INDIA
SANOFI · NSE
3,204.10
+14.60 (+0.46%)
as of 30 Oct 2026 close
Open
3,265.00
High
3,422.60
Low
3,175.10
Prev close
3,189.50
52w high
4,834.00
30 Oct 2025
52w low
2,758.20
23 Oct 2026
VWAP
3,291.78
Delivery %
20.0%
of volume
Volume 2.04 L · turnover ₹67.30 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 11 Jul 2012
- ISIN
- INE058A01010
- Series
- EQ
- Listed on NSE
- 19 May 2003
- Face value
- ₹10
- F&O
- No
Formerly AVENTIS (until 11 Jul 2012). Earlier name: Aventis Pharma Limited (until 11 Jul 2012).
Source: NSE equity master · as of 31 Oct 2026
Daily · NSE EOD
Shareholding · as of 30 Sept 2026
Promoters
60.40%
+0.00 pp QoQ
Public
39.60%
Promoter pledge
0.00%
of promoter shares
26-06
26-09
Promoter share by quarter · source: NSE shareholding filings (XBRL). DIIs include mutual funds and insurers.
Quarterly results · Standalone · latest 30 Sept 2026
filed 29 Oct 2026, 06:35 pm IST| ₹ crore | Jun 26* | Sept 26* |
|---|---|---|
| Revenue | 438 | 492 |
| Other income | 6 | 6 |
| Total expenses | 332 | 340 |
| Operating margin | 26.3% | 32.8% |
| Finance costs | 0 | 0 |
| Depreciation | 9 | 9 |
| Profit before tax | 112 | 158 |
| Tax | 29 | 41 |
| Net profit | 84 | 117 |
| Net margin | 19.1% | 23.7% |
| EPS (₹) | 36.26 | 50.67 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison